Dong S, Wang M, Luo Z, Wu W, Huang H, Yang J, Liang Y, Jiang H, Qiu L. Glofitamab plus polatuzumab vedotin: a novel safe, and highly effective chemotherapy-free regimen for pediatric relapsed/refractory B-cell non-Hodgkin lymphoma. haematol [Internet]. 2020Sep.10 [cited 2026Jun.19];. Available from: https://haematologica.org/article/view/14242